Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Therapy Withdrawal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01685996
What this trial is testing

Zonisamide Augmentation of Varenicline Treatment for Smoking Cessation

Who this might be right for
Nicotine Dependence
Johns Hopkins University 74
Not applicableLooking for participantsNCT07281261
What this trial is testing

TAN for Substance Use Disorder

Who this might be right for
Alcohol Use DisorderAlcohol AbuseSubstance Use Disorders+1 more
Spark Biomedical, Inc. 20
Not applicableStudy completedNCT00796913
What this trial is testing

Remission Induction and Sustenance in Graves' Disease 2

Who this might be right for
Graves DiseaseHyperthyroidism
Aalborg University Hospital 139
Post-approval studies (Phase 4)Study completedNCT03891862
What this trial is testing

Persistence of Effect and Safety of Valbenazine for the Treatment of Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia (TD)
Neurocrine Biosciences 135
Early research (Phase 1)UnknownNCT04744051
What this trial is testing

ATCell™ Expanded Autologous, Adipose-Derived Mesenchymal Stem Cells Deployed Via Intravenous Infusion

Who this might be right for
Post-Concussion Syndrome
American CryoStem Corporation 20
Not applicableLooking for participantsNCT06399653
What this trial is testing

Non-invasive Vagal Nerve Stimulation as Novel Treatment to Improve Functional Outcomes in Veterans With Alcohol Use Disorder

Who this might be right for
Alcohol Use Disorder
VA Office of Research and Development 80
Not applicableStudy completedNCT04378153
What this trial is testing

Impact of Discontinuing Chronic Therapies in People With Cystic Fibrosis on Highly Effective CFTR Modulator Therapy

Who this might be right for
Cystic Fibrosis
Nicole Hamblett 987
Large-scale testing (Phase 3)Study completedNCT02013622
What this trial is testing

Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 49
Not applicableEnded earlyNCT04162145
What this trial is testing

BRIDGE Device for Treatment of Opioid Withdrawal

Who this might be right for
Opioid WithdrawalPainCraving
BrightView LLC 12
Testing effectiveness (Phase 2)Study completedNCT03887429
What this trial is testing

Restoring Cognitive Control (ReCon) in Acute Nicotine Withdrawal

Who this might be right for
Impulse Control Disorders
Promentis Pharmaceuticals, Inc. 34
Early research (Phase 1)Study completedNCT01826266
What this trial is testing

Effects of a Double-Blind, Single Dose of PER977 Administered Alone, and Following a Single Dose of Edoxaban

Who this might be right for
Anticoagulant ReversalReversal of Edoxaban Induced Anticoagulation
Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc. 83
Large-scale testing (Phase 3)Study completedNCT01871649
What this trial is testing

Initial Treatment With Golimumab in Early PsA

Who this might be right for
Psoriatic Arthritis
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 51
Post-approval studies (Phase 4)UnknownNCT00526006
What this trial is testing

PPI-Rebound-Trial. A Study of the Clinical Relevance of the Acid Rebound Phenomena

Who this might be right for
Healthy
Zealand University Hospital
Early research (Phase 1)Study completedNCT00521248
What this trial is testing

Buprenorphine for the Treatment of Neonatal Abstinence Syndrome

Who this might be right for
Neonatal Abstinence Syndrome
Thomas Jefferson University 60
Large-scale testing (Phase 3)Study completedNCT01186744
What this trial is testing

Evaluate The Effects And Safety Of Treatment, Treatment Withdrawal, Followed By Re-Treatment With CP-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Pfizer 666
Post-approval studies (Phase 4)Looking for participantsNCT06653634
What this trial is testing

Optimizing Treatment for Patients With Juvenile Idiopathic Arthritis in Sustained Remission: The MOVE-JIA Trial

Who this might be right for
Juvenile Idiopathic Arthritis
Oslo University Hospital 150
Very early researchUnknownNCT04205682
What this trial is testing

Cannabidiol (CBD) for the Treatment of Alcohol Withdrawal

Who this might be right for
Alcohol WithdrawalAlcohol Dependence
South West Sydney Local Health District 52
Not applicableStudy completedNCT04367051
What this trial is testing

Pilot Study on Withdrawal of Spironolactone Among Heart Failure With Improved Ejection Fraction

Who this might be right for
Heart Failure
Asan Medical Center 62
Large-scale testing (Phase 3)Looking for participantsNCT06128980
What this trial is testing

Withdrawal of Treatment for Heart Failure Patients With Recovery From Tachycardia-induced Cardiomyopathy

Who this might be right for
Heart Failure With Reduced Ejection FractionHeart Rhythm Disorder
Herlev and Gentofte Hospital 348
Post-approval studies (Phase 4)UnknownNCT02426905
What this trial is testing

Study to Assess Long-Term Outcomes of Trientine in Wilson Disease Patients Withdrawn From Therapy With d-Penicillamine

Who this might be right for
Wilson Disease
Univar BV 90
Next Page